Bank of Montreal’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $71.5M | Buy |
1,492,413
+903,306
| +153% | +$38.8M | 0.02% | 484 |
|
|
2026
Q1 | $21.6M | Sell |
589,107
-1,936,720
| -77% | -$91.8M | 0.01% | 820 |
|
|
2025
Q4 | $129M | Buy |
2,525,827
+1,468,409
| +139% | +$75.1M | 0.04% | 318 |
|
|
2025
Q3 | $58.7M | Sell |
1,057,418
-1,417,882
| -57% | -$83M | 0.02% | 451 |
|
|
2025
Q2 | $171M | Buy |
2,475,300
+1,246,467
| +101% | +$84.8M | 0.08% | 180 |
|
|
2025
Q1 | $85.3M | Sell |
1,228,833
-494,104
| -29% | -$40.8M | 0.04% | 293 |
|
|
2024
Q4 | $148M | Buy |
1,722,937
+601,845
| +54% | +$65.1M | 0.07% | 212 |
|
|
2024
Q3 | $135M | Sell |
1,121,092
-79,215
| -7% | -$10.6M | 0.06% | 242 |
|
|
2024
Q2 | $176M | Sell |
1,200,307
-188,294
| -14% | -$25M | 0.05% | 192 |
|
|
2024
Q1 | $179M | Buy |
1,388,601
+48,093
| +4% | +$5.72M | 0.05% | 196 |
|
|
2023
Q4 | $139M | Sell |
1,340,508
-55,181
| -4% | -$5.46M | 0.04% | 243 |
|
|
2023
Q3 | $266M | Sell |
1,395,689
-151,617
| -10% | -$13.4M | 0.09% | 130 |
|
|
2023
Q2 | $125M | Buy |
1,547,306
+46,176
| +3% | +$3.77M | 0.04% | 218 |
|
|
2023
Q1 | $120M | Buy |
1,501,130
+96,712
| +7% | +$6.86M | 0.05% | 217 |
|
|
2022
Q4 | $95.1M | Buy |
1,404,418
+126,592
| +10% | +$7.42M | 0.04% | 252 |
|
|
2022
Q3 | $64.2K | Sell |
1,277,826
-125,224
| -9% | -$6.71M | 0.03% | 308 |
|
|
2022
Q2 | $76.8K | Buy |
1,403,050
+130,922
| +10% | +$7.27M | 0.04% | 293 |
|
|
2022
Q1 | $71.6M | Buy |
1,272,128
+48,140
| +4% | +$2.47M | 0.03% | 351 |
|
|
2021
Q4 | $68.4M | Sell |
1,223,988
-35,564
| -3% | -$1.93M | 0.04% | 347 |
|
|
2021
Q3 | $60.5M | Buy |
1,259,552
+20,306
| +2% | +$982K | 0.03% | 494 |
|
|
2021
Q2 | $52M | Buy |
1,239,246
+821,250
| +196% | +$31.8M | 0.03% | 500 |
|
|
2021
Q1 | $14.5M | Sell |
417,996
-112,642
| -21% | -$4.01M | 0.01% | 828 |
|
|
2020
Q4 | $18.7M | Buy |
530,638
+26,494
| +5% | +$916K | 0.01% | 736 |
|
|
2020
Q3 | $17.4M | Buy |
504,144
+167,084
| +50% | +$5.57M | 0.01% | 630 |
|
|
2020
Q2 | $11.1M | Sell |
337,060
-13,316
| -4% | -$425K | 0.01% | 799 |
|
|
2020
Q1 | $10.4M | Sell |
350,376
-96,522
| -22% | -$2.87M | 0.01% | 695 |
|
|
2019
Q4 | $12.9M | Buy |
446,898
+34,350
| +8% | +$951K | 0.01% | 852 |
|
|
2019
Q3 | $10.7M | Buy |
412,548
+101,850
| +33% | +$2.58M | 0.01% | 857 |
|
|
2019
Q2 | $7.93M | Sell |
310,698
-30,682
| -9% | -$758K | 0.01% | 1001 |
|
|
2019
Q1 | $8.93M | Sell |
341,380
-31,264
| -8% | -$768K | 0.01% | 893 |
|
|
2018
Q4 | $8.59M | Buy |
372,644
+51,536
| +16% | +$1.15M | 0.01% | 840 |
|
|
2018
Q3 | $7.57M | Buy |
321,108
+55,074
| +21% | +$1.34M | 0.01% | 1007 |
|
|
2018
Q2 | $6.13M | Buy |
266,034
+54,336
| +26% | +$1.29M | 0.01% | 1071 |
|
|
2018
Q1 | $5.21M | Buy |
211,698
+54,898
| +35% | +$1.44M | ﹤0.01% | 1128 |
|
|
2017
Q4 | $4.21M | Sell |
156,800
-1,278
| -0.8% | -$32.5K | ﹤0.01% | 1205 |
|
|
2017
Q3 | $3.81M | Sell |
158,078
-3,790
| -2% | -$85.6K | ﹤0.01% | 1287 |
|
|
2017
Q2 | $3.47M | Buy |
161,868
+31,512
| +24% | +$636K | ﹤0.01% | 1334 |
|
|
2017
Q1 | $2.23M | Buy |
130,356
+51,222
| +65% | +$892K | ﹤0.01% | 1472 |
|
|
2016
Q4 | $1.33M | Buy |
79,134
+10,570
| +15% | +$192K | ﹤0.01% | 1776 |
|
|
2016
Q3 | $1.43M | Sell |
68,564
-28,782
| -30% | -$714K | ﹤0.01% | 1658 |
|
|
2016
Q2 | $2.62M | Buy |
97,346
+8,468
| +10% | +$232K | ﹤0.01% | 1379 |
|
|
2016
Q1 | $2.41M | Sell |
88,878
-39,406
| -31% | -$1.06M | ﹤0.01% | 1352 |
|
|
2015
Q4 | $3.73M | Buy |
128,284
+17,784
| +16% | +$492K | ﹤0.01% | 1104 |
|
|
2015
Q3 | $3M | Sell |
110,500
-9,512
| -8% | -$269K | ﹤0.01% | 1134 |
|
|
2015
Q2 | $3.29M | Buy |
120,012
+3,082
| +3% | +$86.6K | ﹤0.01% | 1200 |
|
|
2015
Q1 | $3.12M | Sell |
116,930
-2,734
| -2% | -$63K | ﹤0.01% | 1201 |
|
|
2014
Q4 | $2.53M | Buy |
119,664
+12,590
| +12% | +$281K | ﹤0.01% | 1312 |
|
|
2014
Q3 | $2.55M | Sell |
107,074
-39,308
| -27% | -$905K | ﹤0.01% | 1357 |
|
|
2014
Q2 | $3.38M | Sell |
146,382
-8,076
| -5% | -$178K | ﹤0.01% | 1235 |
|
|
2014
Q1 | $3.52M | Buy |
154,458
+10,878
| +8% | +$232K | ﹤0.01% | 1071 |
|
|
2013
Q4 | $2.65M | Sell |
143,580
-5,940
| -4% | -$104K | ﹤0.01% | 1066 |
|
|
2013
Q3 | $2.53M | Buy |
149,520
+97,560
| +188% | +$1.64M | ﹤0.01% | 1055 |
|
|
2013
Q2 | $805K | Buy |
+51,960
| New | +$865K | ﹤0.01% | 1495 |
|
Other funds holding NVO
F
EHC
Bank of Montreal's NVO Position: Q2 2026 in Review
Bank of Montreal increased its Novo Nordisk (NVO) stake by 153% in Q2 2026, buying an estimated $38.8M and bringing the position to 1,492,413 shares worth $71.5M. The position accounts for 0.02% of the portfolio, ranked #484.
Bank of Montreal first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $266M in Q3 2023. 1,191 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Bank of Montreal held 1,492,413 shares of Novo Nordisk worth $71.5M as of Q2 2026.
- Bank of Montreal bought 903,306 Novo Nordisk shares in Q2 2026, an estimated $38.8M.
- Novo Nordisk made up 0.02% of Bank of Montreal's portfolio in Q2 2026, its #484 holding.
- Bank of Montreal first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Novo Nordisk position peaked at $266M in Q3 2023.
- 1,191 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.